AGIO
Price
$33.63
Change
+$0.16 (+0.48%)
Updated
Jun 30, 10:34 AM (EDT)
Capitalization
1.94B
31 days until earnings call
THAR
Price
$1.80
Change
+$0.04 (+2.27%)
Updated
Jun 27 closing price
Capitalization
7.59M
Interact to see
Advertisement

AGIO vs THAR

Header iconAGIO vs THAR Comparison
Open Charts AGIO vs THARBanner chart's image
Agios Pharmaceuticals
Price$33.63
Change+$0.16 (+0.48%)
Volume$600
Capitalization1.94B
Tharimmune
Price$1.80
Change+$0.04 (+2.27%)
Volume$41.41K
Capitalization7.59M
AGIO vs THAR Comparison Chart in %
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. THAR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Buy and THAR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AGIO: $33.47 vs. THAR: $1.80)
Brand notoriety: AGIO and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 88% vs. THAR: 38%
Market capitalization -- AGIO: $1.94B vs. THAR: $7.59M
AGIO [@Biotechnology] is valued at $1.94B. THAR’s [@Biotechnology] market capitalization is $7.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, AGIO is a better buy in the long-term than THAR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while THAR’s TA Score has 5 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 5 bearish.
  • THAR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, THAR is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а -2.73% price change this week, while THAR (@Biotechnology) price change was +34.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.16%. For the same industry, the average monthly price growth was +33.49%, and the average quarterly price growth was +7.40%.

Reported Earning Dates

AGIO is expected to report earnings on Jul 31, 2025.

THAR is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+4.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($1.94B) has a higher market cap than THAR($7.59M). AGIO has higher P/E ratio than THAR: AGIO (2.90) vs THAR (0.02). AGIO YTD gains are higher at: 1.856 vs. THAR (-11.207). THAR has higher annual earnings (EBITDA): -12.47M vs. AGIO (-434.71M). AGIO has more cash in the bank: 893M vs. THAR (1.08M). THAR has less debt than AGIO: THAR (271K) vs AGIO (52.9M). AGIO has higher revenues than THAR: AGIO (37M) vs THAR (0).
AGIOTHARAGIO / THAR
Capitalization1.94B7.59M25,527%
EBITDA-434.71M-12.47M3,487%
Gain YTD1.856-11.207-17%
P/E Ratio2.900.0212,557%
Revenue37M0-
Total Cash893M1.08M82,993%
Total Debt52.9M271K19,520%
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOTHAR
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 27 days ago
76%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HISIX10.920.11
+1.02%
Homestead International Equity
PIEQX18.850.16
+0.86%
T. Rowe Price International Eq Index
CHFTX22.770.16
+0.71%
Invesco Charter R6
LRSVX20.350.10
+0.49%
Lord Abbett Small Cap Value R6
SCWFX70.940.22
+0.31%
American Funds SMALLCAP World F1

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with INSM. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+2.41%
INSM - THAR
74%
Closely correlated
-2.21%
RAIN - THAR
52%
Loosely correlated
+5.79%
CMND - THAR
50%
Loosely correlated
-1.21%
SNGX - THAR
46%
Loosely correlated
-0.73%
AGIO - THAR
37%
Loosely correlated
-0.53%
More